Peer-reviewed veterinary case report
Signs, diagnosis, and survival in 182 dogs with unknown brain
By Paušová, Tereza Kosinová et al.·Published in Topics in companion animal medicine·2021·Jaggy Referral Veterinary Clinic·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Clinical Presentation, Diagnostic Findings, and Long-term Survival Time in 182 Dogs With Meningoencephalitis of Unknown Origin From Central Europe That Were Administered Glucocorticosteroid Monotherapy.
- Species:
- dog
Plain-English summary
A group of 182 dogs diagnosed with meningoencephalitis of unknown origin (MUO), a serious brain condition, were treated with glucocorticosteroids to see how well they responded. The dogs showed various neurological symptoms, and after treatment, more than half survived for over a year, with some living more than five years. The study found that dogs with brainstem lesions had a better chance of surviving longer compared to those with multiple brain lesions. Overall, glucocorticosteroids proved to be an effective treatment for this condition.
People also search for: dog meningoencephalitis treatment · glucocorticosteroids for dogs · dog brain disease symptoms
Abstract
Canine non-infectious inflammatory meningoencephalomyelitis is termed meningoencephalomyelitis of unknown origin (MUO) and may affect dogs of every breed at any age. Treatment with immunosuppressive medication, the survival time based on MRI, and cerebrospinal fluid (CSF) findings has been widely reported; however, these studies only included a small number of patients, or they are summaries from the literature. Therefore, the aim of this study was to compare the clinical presentation, diagnostic findings, treatment protocol and long-term survival time in many dogs diagnosed with MUO in one clinic with previously published studies. One hundred eighty-two dogs met the inclusion criteria. Age, sex, duration of clinical signs before diagnosis, presence of neurological signs, MRI and CSF analysis were similar to those in previous reports. Our study revealed that dogs with a brainstem lesion have a 60% lower chance of death before 1 year than dogs with multifocal brain lesions. A total of 55.56% of treated dogs survived for more than 1 year, and 10.55% survived for more than 5 years since diagnosis. The median survival time for all dogs was 540 days. Our findings support glucocorticosteroid monotherapy as a viable treatment option for dogs with MUO.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/33964477/